Nurix CSO Gwenn Hansen sells 4,111 shares for $100,068.32
NRIX•Nurix CSO Gwenn Hansen sells shares
- Nurix Therapeutics Chief Scientific Officer Gwenn Hansen sold 4,111 common shares on Aug. 4.
- Sales priced at USD 23.87 and USD 24.64 per share.
- Post-transaction direct holdings totaled 117,227 common shares.
